" />
Breast cancer 10Y risk of distant recurrence panel:-:Pt: Patient:-:Prosigna - CISMeF
Breast cancer 10Y risk of distant recurrence panel:-:Pt: Patient:-:ProsignaLOINC code
Preferred Label : Breast cancer 10Y risk of distant recurrence panel:-:Pt: Patient:-:Prosigna;
LOINC status : ACTIVE;
LOINC display name : Breast cancer 10-year risk of distant recurrence panel Prosigna;
LOINC long common name : Breast cancer 10-year risk of distant recurrence panel by Prosigna;
LOINC short name : Brst ca 10Y risk dist recur Pnl Prosigna;
LOINC description : A 10-year breast cancer distant recurrence risk panel created for the Prosigna Breast
Cancer Prognostic Gene Signature assay, which is intended for use in postmenopausal
women with node-negative (Stage I or II) or node-positive (Stage II), hormone receptor-positive
(HR ) breast cancer who have undergone surgery and are to be treated with adjuvant
endocrine therapy alone. The panel includes terms for primary tumor size, lymph node
status, distant recurrence risk score, and distance recurrence risk classification.
The 10-year breast cancer distant recurrence risk score (also referred to as ROR Score
or Risk of Recurrence Score) is a numerical score on a scale of 0 -100 that is calculated
using a statistical model that includes: 1) the results from a 50-gene expression
assay performed on formalin fixed paraffin embedded breast tumor tissue previously
diagnosed as invasive carcinoma; 2) proliferation score; and 3) gross tumor size.
The calculated score and information about lymph node status are used together to
classify the patient into a risk category for distant breast cancer recurrence at
10 years.;
Has component